SE453509B - D-fenylalanyl-l-prolyl-l-arginin-aldehydsulfat och farmaceutisk komposition innehallande detsamma - Google Patents

D-fenylalanyl-l-prolyl-l-arginin-aldehydsulfat och farmaceutisk komposition innehallande detsamma

Info

Publication number
SE453509B
SE453509B SE8200135A SE8200135A SE453509B SE 453509 B SE453509 B SE 453509B SE 8200135 A SE8200135 A SE 8200135A SE 8200135 A SE8200135 A SE 8200135A SE 453509 B SE453509 B SE 453509B
Authority
SE
Sweden
Prior art keywords
phenylalanyl
prolyl
aldehyde
arginine
sulphate
Prior art date
Application number
SE8200135A
Other languages
English (en)
Swedish (sv)
Other versions
SE8200135L (sv
Inventor
S Bajusz
E Szell
E Barabas
D Bagdy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8200135L publication Critical patent/SE8200135L/xx
Publication of SE453509B publication Critical patent/SE453509B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8200135A 1981-01-13 1982-01-12 D-fenylalanyl-l-prolyl-l-arginin-aldehydsulfat och farmaceutisk komposition innehallande detsamma SE453509B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8170A HU184368B (en) 1981-01-13 1981-01-13 Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate

Publications (2)

Publication Number Publication Date
SE8200135L SE8200135L (sv) 1982-07-14
SE453509B true SE453509B (sv) 1988-02-08

Family

ID=10947750

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200135A SE453509B (sv) 1981-01-13 1982-01-12 D-fenylalanyl-l-prolyl-l-arginin-aldehydsulfat och farmaceutisk komposition innehallande detsamma

Country Status (23)

Country Link
US (2) US4399065A (es)
JP (1) JPS57181046A (es)
AT (1) AT383352B (es)
AU (1) AU544492B2 (es)
BE (1) BE891708A (es)
CA (1) CA1182111A (es)
CH (1) CH649305A5 (es)
DE (1) DE3200812C2 (es)
DK (1) DK151341C (es)
ES (1) ES8301205A1 (es)
FI (1) FI74024C (es)
FR (1) FR2497799B1 (es)
GB (1) GB2091270B (es)
HU (1) HU184368B (es)
IL (1) IL64761A (es)
IT (1) IT1210842B (es)
MX (1) MX156383A (es)
NL (1) NL8200105A (es)
NO (1) NO158021C (es)
PL (1) PL133451B1 (es)
PT (1) PT74268B (es)
SE (1) SE453509B (es)
SU (1) SU1442078A3 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
EP0316965A3 (en) * 1983-02-07 1989-08-09 Aktiebolaget Hässle Enzyme inhibitors
DE3481913D1 (de) * 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
DE3606480A1 (de) * 1986-02-28 1987-09-03 Behringwerke Ag Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung
US5023236A (en) * 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
GB2244994B (en) * 1990-06-12 1994-01-19 Richter Gedeon Vegyeszet Improved process for the preparation of tripeptide aldehydes
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
US5250660A (en) * 1991-11-12 1993-10-05 Eli Lilly And Company Peptide purification process
US5416093A (en) * 1991-11-12 1995-05-16 Eli Lilly And Company Antithrombotic agents
US5252566A (en) * 1991-11-12 1993-10-12 Eli Lilly And Company Antithrombotic agents
CA2131367A1 (en) * 1992-03-04 1993-09-16 Sandor Bajusz New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
EP0583534B1 (en) * 1992-08-14 1997-03-05 The Procter & Gamble Company Liquid detergents containing a peptide aldehyde
US5576283A (en) * 1992-08-14 1996-11-19 The Procter & Gamble Company Liquid detergents containing a peptide aldehyde
US5582762A (en) * 1992-08-14 1996-12-10 The Procter & Gamble Company Liquid detergents containing a peptide trifluoromethyl ketone
US5371072A (en) * 1992-10-16 1994-12-06 Corvas International, Inc. Asp-Pro-Arg α-keto-amide enzyme inhibitors
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
WO1994017817A1 (en) * 1993-02-12 1994-08-18 Corvas International, Inc. Inhibitors of thrombosis
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5932733A (en) * 1994-06-17 1999-08-03 Corvas International, Inc. 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors
US5658930A (en) * 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5656645A (en) * 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
DE19605039A1 (de) 1996-02-12 1997-08-14 Hoechst Ag Verfahren zur Herstellung von Oligopeptid-Aldehyden
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
IT1283467B1 (it) * 1996-07-19 1998-04-21 Menarini Farma Ind Derivati di cicloalcani 1,2 sostituiti come inibitori della trombina, procedimento per la loro preparazione e loro impiego in formulazioni
US6165966A (en) * 1996-09-24 2000-12-26 The Procter & Gamble Company Liquid detergents containing proteolytic enzyme and protease inhibitors
US6180586B1 (en) 1996-09-24 2001-01-30 The Procter & Gamble Company Liquid laundry detergent compositions containing proteolytic enzyme and protease inhibitors
CA2266497C (en) * 1996-09-24 2002-12-31 John Mcmillan Mciver Liquid detergents containing proteolytic enzyme and protease inhibitors
US7090455B2 (en) * 1998-11-13 2006-08-15 Pneutools, Incorporated Stacked assembly of roofing caps
US20110028397A1 (en) * 2007-11-30 2011-02-03 Toezser Jozsef Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders
EP2343310A1 (en) * 2010-01-08 2011-07-13 Novozymes A/S Serine hydrolase formulation
CN107858217B (zh) 2011-07-01 2021-03-23 诺维信公司 稳定化的枯草杆菌蛋白酶组合物
WO2016001319A1 (en) 2014-07-03 2016-01-07 Novozymes A/S Improved stabilization of non-protease enzyme
DE102015208655A1 (de) 2015-05-11 2016-11-17 Henkel Ag & Co. Kgaa Enzymstabilisatoren
DE102015210828A1 (de) 2015-06-12 2016-12-15 Henkel Ag & Co. Kgaa Phosphatfreies flüssiges Geschirrspülmittel
DE102016209406A1 (de) 2016-05-31 2017-11-30 Henkel Ag & Co. Kgaa Stabilisierte Enzym-haltige Wasch- und Reinigungsmittel
DE102017219993A1 (de) 2017-11-09 2019-05-09 Henkel Ag & Co. Kgaa Enzymhaltiges Wasch- oder Reinigungsmittel
DE102018129277A1 (de) 2018-11-21 2020-05-28 Henkel Ag & Co. Kgaa Mehrkomponenten Wasch- oder Reinigungsmittel enthaltend eine Chinon-Oxidoreduktase
MX2021015894A (es) 2019-07-01 2022-02-03 Basf Se Peptidos acetales para estabilizar enzimas.
EP3770237A1 (de) 2019-07-22 2021-01-27 Henkel AG & Co. KGaA Wasch- und reinigungsmittel mit verbesserter enzym-stabilität
US20240240114A1 (en) 2020-09-22 2024-07-18 Basf Se Improved Combination of Protease and Protease Inhibitor with Secondary Enzyme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826793A (en) * 1968-10-21 1974-07-30 Bofors Ab Anticoagulant peptides related to fibrino peptides
HU169870B (es) * 1974-06-14 1977-02-28
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate

Also Published As

Publication number Publication date
NO820083L (no) 1982-07-14
CA1182111A (en) 1985-02-05
PT74268A (en) 1982-02-01
AT383352B (de) 1987-06-25
NO158021B (no) 1988-03-21
DK151341B (da) 1987-11-23
IT1210842B (it) 1989-09-29
SE8200135L (sv) 1982-07-14
GB2091270B (en) 1984-08-22
ES508637A0 (es) 1982-11-16
CH649305A5 (de) 1985-05-15
FR2497799A1 (fr) 1982-07-16
DE3200812A1 (de) 1982-08-12
FI74024B (fi) 1987-08-31
SU1442078A3 (ru) 1988-11-30
NO158021C (no) 1988-06-29
ATA9782A (de) 1986-11-15
PT74268B (en) 1983-06-27
DK151341C (da) 1988-05-09
IT8219074A0 (it) 1982-01-12
FR2497799B1 (fr) 1985-06-28
PL133451B1 (en) 1985-06-29
JPS57181046A (en) 1982-11-08
GB2091270A (en) 1982-07-28
DE3200812C2 (de) 1986-09-18
IL64761A0 (en) 1982-03-31
AU7944682A (en) 1982-07-22
FI820086L (fi) 1982-07-14
NL8200105A (nl) 1982-08-02
JPH0251920B2 (es) 1990-11-08
FI74024C (fi) 1987-12-10
DK9382A (da) 1982-07-14
ES8301205A1 (es) 1982-11-16
AU544492B2 (en) 1985-05-30
BE891708A (fr) 1982-07-07
MX156383A (es) 1988-08-16
IL64761A (en) 1985-01-31
US4399065A (en) 1983-08-16
HU184368B (en) 1984-08-28
PL234696A1 (es) 1982-09-13
US4478745A (en) 1984-10-23

Similar Documents

Publication Publication Date Title
SE453509B (sv) D-fenylalanyl-l-prolyl-l-arginin-aldehydsulfat och farmaceutisk komposition innehallande detsamma
US4388304A (en) Angiotensin-II analogues with antagonizing effects, containing an ester group in position 8, and a process for the preparation thereof
US4316889A (en) Novel peptidyl-arginine aldehyde derivatives and process for the preparation thereof
EP0384362B1 (de) Glycinderivate
US4024248A (en) Peptides having LH-RH/FSH-RH activity
US4612365A (en) Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4910296A (en) Medicaments containing alpha 1 thymosin fragments and having an immunostimulant action, and fragments of alpha 1 thymosin
EP0112656B1 (en) Peptide compounds
US3345354A (en) Intermediate in the synthesis of alpha1-24 acth
SE452326B (sv) Salter av agmatinderivat och farmaceutiska preparat innehallande desamma
US3479333A (en) D-phe**7-alpha**1-10-a.c.t.h. and derivatives and complexes thereof
EP1485345B1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
EP0249169B1 (de) Peptide mit Einfluss auf die Diurese und Natriurese, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
US3920627A (en) Position 1 analogs of {8 phenylglycyl{9 -angiotension II
US4371466A (en) Mammalian collagenase inhibitors
DE2831271C2 (de) Heptapeptide, Verfahren zu ihrer Herstellung und diese Heptapeptide enthaltende, angiotensin-II-antagonistisch wirkende Arzneimittel
IE42369B1 (en) Peptide derivatives having an antihypertensive effect and process for their manufacture
US3770715A (en) Acth active peptides having d serine as first aminoacid from n terminus and l ornithine as11 aminoacid
US4330532A (en) Angiotensin-II analogues with antagonizing effects, containing an α-hydroxycarboxylic acid residue in position 8, and a process for the preparation thereof
SE469032B (sv) Gonadoliberinderivat och farmaceutisk komposition innehaallande dessa
US4405607A (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
EP0080194B1 (de) Neue Peptide und Verfahren zu ihrer Herstellung
DE1493559C3 (de) Neue Peptide mit adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung
DE1643282A1 (de) Verfahren zur Herstellung neuer Peptide mit ACTH-Wirkung
Mezö et al. New Gaba-containing analogues of human Growth Hormone-Releasing Hormone (1–30)-amide: I. Synthesis and in vitro biological activity

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200135-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200135-5

Format of ref document f/p: F